Association of early vedolizumab trough levels with clinical, biochemical, endoscopic response and drug optimization during maintenance therapy in patients with inflammatory bowel diseases. - Kim K; Yoon AR; Oh K; Hong HS; Lee JY; Hong SW; Hwang SW; Park SH; Yang DH; Byeon JS; Myung SJ; Ye BD (Scientific reports, 2026)